Table 2.
ASYR | ASMR | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1988–1992 | 1993–1997 | 1998–2002 | 2003–2007 | 2008–2012 | 2013–2017 | 1988–1992 | 1993–1997 | 1998–2002 | 2003–2007 | 2008–2012 | 2013–2017 | |
C00-C97: all cancer | 4510 | 4306 | 4137 | 4061 | 3997 | 3823 | 353 | 333 | 315 | 302 | 289 | 275 |
C33-C34: lung | 1095 | 995 | 922 | 899 | 901 | 837 | 84 | 77 | 70 | 66 | 64 | 60 |
C50: breast | 1004 | 903 | 803 | 737 | 675 | 612 | 58 | 52 | 46 | 42 | 38 | 34 |
C61: prostate | 418 | 430 | 420 | 426 | 414 | 396 | 58 | 59 | 56 | 54 | 50 | 48 |
C18-C20: bowel | 489 | 442 | 401 | 386 | 373 | 354 | 43 | 38 | 34 | 31 | 29 | 27 |
C56-C57.4: ovary | 295 | 289 | 281 | 261 | 238 | 216 | 17 | 17 | 16 | 15 | 14 | 13 |
C25: pancreas | 181 | 172 | 177 | 190 | 206 | 211 | 15 | 14 | 14 | 14 | 15 | 15 |
C15: oesophagus | 160 | 177 | 186 | 195 | 198 | 190 | 13 | 14 | 14 | 14 | 14 | 13 |
C22: liver | 49 | 58.6 | 65 | 80 | 103 | 126 | 4 | 4 | 5 | 6 | 7 | 9 |
C91-C95: leukaemia | 128 | 123 | 125 | 121 | 118 | 109 | 9 | 8 | 8 | 8 | 8 | 8 |
C82-C86: non-Hodgkin lymphoma | 124 | 134 | 134 | 123 | 114 | 109 | 9 | 9 | 9 | 9 | 8 | 8 |
C64-C66,C68: kidney | 87 | 91 | 93 | 102 | 106 | 105 | 6 | 6 | 7 | 7 | 7 | 7 |
C54-C55: uterus | 81 | 72 | 75 | 82 | 94 | 104 | 6 | 5 | 5 | 6 | 6 | 7 |
C16: stomach | 245 | 197 | 164 | 135 | 116 | 101 | 22 | 17 | 14 | 11 | 9 | 8 |
C67: bladder | 125 | 116 | 106 | 101 | 100 | 96 | 12 | 11 | 10 | 10 | 9 | 9 |
C53: cervix | 163 | 121 | 94 | 79 | 74 | 68 | 7 | 6 | 4 | 4 | 3 | 3 |
C43: melanoma skin cancer | 48 | 55 | 58 | 62 | 67 | 66 | 3 | 3 | 3 | 4 | 4 | 4 |
C90: myeloma | 61 | 62 | 62 | 63 | 61 | 61 | 5 | 5 | 5 | 5 | 5 | 5 |
Cancer sites are sorted by the ASYR in the period 2013–2017.